Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs

Cytokine Growth Factor Rev. 2024 Apr:76:48-76. doi: 10.1016/j.cytogfr.2023.12.007. Epub 2024 Jan 2.

Abstract

This concise review navigates the intricate realm of Interleukin-6 (IL-6), an important member of the cytokine family. Beginning with an introduction to cytokines, this narrative review unfolds with the historical journey of IL-6, illuminating its evolving significance. A crucial section unravels the three distinct signaling modes employed by IL-6, providing a foundational understanding of its versatile interactions within cellular landscapes. Moving deeper, the review meticulously dissects IL-6's signaling mechanisms, unraveling the complexities of its pleiotropic effects in both physiological responses and pathological conditions. A significant focus is dedicated to the essential role IL-6 plays in inflammatory diseases, offering insights into its associations and implications for various health conditions. The review also takes a therapeutic turn by exploring the emergence of anti-IL-6 monoclonal inhibitors, marking a profound stride in treatment modalities. Diving into the molecular realm, the review explores small molecules as agents for IL-6 inhibition, providing a nuanced perspective on diverse intervention strategies. As the review embarks on the final chapters, it contemplates future aspects, offering glimpses into potential research trajectories and the evolving landscape of IL-6-related studies.

Keywords: IL-6 monoclonal antibodies; Inflammatory diseases; Interleukin-6 signaling; Small molecules.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytokines*
  • Humans
  • Interleukin-6*
  • Signal Transduction

Substances

  • Interleukin-6
  • Cytokines